TENVIR-EM (tenofovir/emtricitabine) Coupons, Discounts & Cost

TENVIR-EM (tenofovir/emtricitabine) Coupons, Discounts & Cost
Click to Open Site
GSMeds.to ( visit store )
0 0
Comments Off
Want to say something? Add Comment 

Tenvir-EM (tenofovir/emtricitabine) Coupons, Discounts & Cost

Tenvir-EM is the official generic of Truvada (antiretroviral drug). One way to save money on the Tenvir-EM retail cost regardless of income and insurance status is to use Tenvir-EM coupons or discount cards from RXCoupons. Use this Tenofovir/Emtricitabine coupon at this online pharmacy and receive up to 75% off the sale price.

Tenvir-EM indications

Tenvir-EM is the official generic of Truvada (antiretroviral drug). Tenvir-EM is a combination of emtricitabine and tenofovir disoproxil fumarate. This drug has specific activity against HIV-1, HIV-2 and Hepatitis B virus.

Tenvir-EM can be taken by persons over 18 years of age in combination with similar drugs (other antiretroviral drugs). Tenvir helps combat HIV infections and prevent the virus from spreading in the human body.

Tenvir-EM should be avoided in case of hypersensitivity to any of the components of the drug.

How can I use Tenvir-EM?

It is necessary to consult with a doctor who has experience in the treatment of HIV infection.

The recommended dose of Tenvir-EM is 1 tablet, which is taken once a day during meals.

As for recommendations regarding dosing for patients of the age of 65 years, there is no need to change the recommended daily dose.

As for renal insufficiency, Tenvir-EM can be used if the potential benefit of treatment is considered to outweigh the potential risks. It is recommended to use Tenvir-EM every 48 hours in case of moderate renal failure.

Tenvir-EM is not recommended for patients with severe renal impairment and patients who need hemodialysis.

Tenvir-EM side effects

Blood and lymphatic system: often – neutropenia; rarely – anemia.

Immune system: often – allergic reactions.

Metabolism: very often – hypophosphatemia, hyperglycemia, hypertriglyceridemia, lactic acidosis; rarely – hypokalemia.

Mental disorders: often – insomnia, abnormal dreams.

CNS: very often – headache, dizziness.

Respiratory disorders: rarely – shortness of breath.

Digestive system: very often – diarrhea, vomiting, nausea; often – abdominal pain, indigestion, flatulence; rarely – pancreatitis.

Hepatobiliary system: often – hyperbilirubinemia: rarely – hepatitis, fatty liver disease.

Skin and subcutaneous tissue: often – urticaria, rash, itching, rash, increased pigmentation.

Musculoskeletal system: very often – rhabdomyolysis, osteomalacia (bone pain, fractures), muscle weakness, myopathy.

Urinary system: rarely – renal failure (acute and chronic), proteinuria, acute tubular necrosis, nephritis (including acute interstitial nephritis).

Antiretroviral combination therapy has been associated with metabolic abnormalities (such as hypertriglyceridemia, hypercholesterolemia, insulin resistance, hyperglycemia and hyperlactatemia) and lipodystrophy (including loss of peripheral and facial subcutaneous fat, breast hypertrophy).

Tenvir-EM therapy during pregnancy or lactation

Tenvir-EM is used during pregnancy only in life-threatening circumstances.

HIV-infected mothers should not breastfeed to prevent the risk of postnatal transmission of HIV.

It is not recommended to use Tenvir-EM in children under the age of 18.

Tenvir-EM special instructions

Tenvir-EM should not be combined with other drugs containing emtricitabine, tenofovir DF, lamivudine and zalcitabine. There is a close structural similarity between lamivudine and emtricitabine.

Patients who use Tenvir-EM or any other antiretroviral therapy may also suffer from opportunistic infections and other complications of HIV infection. Therefore, they must remain under close clinical supervision.

Patients should be informed that there is no evidence that certain antiretroviral treatment (including Tenvir-EM) prevents the risk of HIV transmission through sexual contact or blood.

Tenvir-EM should not be used with nephrotoxic drugs.

Patients with liver function abnormalities (including chronic hepatitis) have a higher risk of hepatic impairment during Tenvir-EM therapy.

Tenvir-EM should not be used in the treatment of patients with lactose intolerance or allergy to any of the components of the drug. It is also necessary to inform your doctor about hepatitis, obesity, kidney disease or alcohol dependence in order to prevent dangerous complications. It is important to inform your doctor about pregnancy or lactation, allergies, other diseases (including chronic ones), as well as about taking other drugs, food additives or herbal products.

You should immediately seek emergency medical attention in case of allergic reactions or hypersensitivity reactions. Common symptoms may include hives, swelling, skin rash, chest pain, shortness of breath.

Keep the drug in a dry place, protected from sun and inaccessible to children. Keep it at a temperature of 15 to 30° C.

Comments are closed.